๐
Cardiac Monitoring
Heart Rate & Variability
Continuous ECG monitoring with AI pattern recognition to detect cardiovascular changes during allergic reactions.
Revolutionary wearable device that detects early signs of anaphylaxis using advanced biometric monitoring. Currently in prototype development.
"Our Above Band prototype successfully detected and alerted to anaphylaxis in our founder's daughter, providing crucial early warning that enabled immediate intervention."
Continuous monitoring of vital signs to detect the earliest stages of anaphylaxis
Monitors heart rate patterns and variability to detect cardiovascular changes that occur during allergic reactions.
Tracks body temperature fluctuations and skin temperature changes associated with allergic responses.
Continuous SpO2 monitoring to detect respiratory compromise before symptoms become severe.
Advanced sensors measure stress hormones and autonomic nervous system responses to allergenic exposure.
AI algorithms analyze biometric patterns to provide early warnings 5-10 minutes before severe symptoms develop.
Automatic alerts to caregivers, emergency contacts, and healthcare providers with location data and severity assessment.
Current prototype status and testing milestones
Our current prototype successfully detected anaphylaxis in real-world testing, including a confirmed case with our founder's daughter, providing 8-minute early warning.
Working with allergists to validate detection algorithms across different patient populations and anaphylaxis triggers.
Limited beta testing program for high-risk patients working with our clinical team. Join the waitlist for early access.
Planned features include medication delivery integration, GPS emergency services, and predictive trigger avoidance algorithms.
Advanced sensor technology designed for life-threatening allergy detection
Real-world prototype testing results
"The Above Band detected my daughter's anaphylaxis 8 minutes before she felt any symptoms. We had her EpiPen ready and avoided an emergency."
"The biometric data showed cardiovascular changes that our clinical team recognized as early anaphylaxis indicators. This technology will save lives."
"For families living with severe food allergies, this kind of early detection technology provides peace of mind we've never had before."
Be among the first to experience breakthrough anaphylaxis detection technology.
Join Beta ProgramLimited beta testing spots โข High-risk patients prioritized